Muhammad Salim - Mayo Clinic and Mayo Foundation

Muhammad Salim

Mayo Clinic and Mayo Foundation

United States

Muhammad Salim - Mayo Clinic and Mayo Foundation

Muhammad Salim

Introduction

Primary Affiliation: Mayo Clinic and Mayo Foundation - United States

Publications

17Publications

554Reads

10Profile Views

194PubMed Central Citations

Diagnosis and Management of Spinal Metastasis of Glioblastoma.

Can J Neurol Sci 2015 Nov 27;42(6):410-3. Epub 2015 Aug 27.

2CancerCare Manitoba,Winnipeg,Manitoba.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cjn.2015.285DOI Listing
November 2015
5 Reads
1 Citation
1.600 Impact Factor

Phase II study of PX-866 in recurrent glioblastoma.

Neuro Oncol 2015 Sep 20;17(9):1270-4. Epub 2015 Jan 20.

CancerCare Manitoba, Winnipeg, Canada (M.W.P., S.B.); Queen's University, Department of Oncology, Kingston, Canada (E.A.E.); Dalhousie University,Halifax, Canada (M.V.M.); BritishColumbia Cancer Agency, Vancouver, Canada (B.T.); Tom Baker Cancer Centre, Calgary, Canada (J.C.E.); London Regional Cancer Program, London, Canada (D.R.M.); University of Alberta, Edmonton, Canada (D.D.E.); Allan Blair Cancer Center, Regina, Canada (A.S.K., M.S., H.C.); Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada (J.S.); Department of Pathology, University Health Network, University of Toronto, Toronto, Canada (M.S.T., S.K.-R.); NCIC Clinical Trials Group, Queen's University, Kingston, Canada (D.T., J.P.); Oncothyreon, Inc., Seattle, Washington (D.F.H.); Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (W.P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588751PMC
September 2015
30 Reads
20 Citations
5.562 Impact Factor

SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.

J Clin Oncol 2015 Jan 24;33(1):58-64. Epub 2014 Nov 24.

George T. Budd, Halle C. F. Moore, Cleveland Clinic, Cleveland; Timothy D. Moore, Mid Ohio Oncology Hematology, Columbus, OH; William E. Barlow, Danika L. Lew, SWOG Statistical Center; Kristine J. Rinn, Swedish Cancer Institute; Julie R Gralow, Seattle Cancer Care Alliance, Seattle, WA; Timothy J. Hobday Mayo Clinic, Rochester, MN; James A. Stewart, Baystate Medical Center, Springfield, MA; Claudine Isaacs, Georgetown University, Washington, DC; Muhammad Salim, Allan Blair Cancer Centre, Regina, Saskatchewan, Canada; Jonathan K. Cho, University of Hawaii MBCCOP, Honolulu, HI; Kathy S. Albain, Loyola University Chicago, Stritch School of Medicine; Chicago, IL; Helen K. Chew, University of California-Davis, Sacramento, CA; Gary V. Burton, Louisiana State University Health Sciences Center, Shreveport, LA; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Lawrence E. Flaherty, Karmanos Cancer Institute/Wayne State University, Detroit, MI; Bradley A. McGregor, Willford Hall Medical Center, Lackland Air Force Base; Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert B. Livingston, Arizona Cancer Center, Tucson, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.3296DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268253PMC
January 2015
111 Reads
17 Citations
18.430 Impact Factor

Supplement use during an intergroup clinical trial for breast cancer (S0221).

Breast Cancer Res Treat 2013 Feb 10;137(3):903-13. Epub 2013 Jan 10.

Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2400-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552360PMC
February 2013
21 Reads
7 Citations
3.940 Impact Factor

Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer.

Clin Colorectal Cancer 2007 May;6(7):516-21

Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CCC.2007.n.017DOI Listing
May 2007
10 Reads
3 Citations
2.910 Impact Factor